Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

F Marc de Lacharriere Fimalac SA Acquires 98% of Allocine Group


Tuesday, 16 Jul 2013 02:30am EDT 

F Marc de Lacharriere Fimalac SA (Fimalac) announced that following on from the exclusive talks held with the shareholders of Allocine Group, it has acquired 98% of all outstanding Allocine Group shares for EUR 66.9 million. 

Company Quote

55.48
0.0 +0.00%
11:35am EST